As at‑home self‑administration of medication becomes increasingly popular and biopharmaceutical enterprises keep expanding production capacity, the market for high‑end integrated drug‑delivery packaging is enjoying broad growth prospects. Especially in high‑frequency scenarios including long‑term management of chronic diseases, centralized outpatient injection and primary‑care treatment, demands for convenient, safe and efficient drug‑delivery methods are growing more urgent. To address these challenges, glass cartridges have become the preferred solution for high‑end integrated drug‑delivery packaging. With an integrally‑formed fully‑sealed structure, the cartridge maintains full closure after filling, eliminating secondary sub‑packaging and liquid‑extraction procedures, and preventing cross‑contamination and dosing errors at the source. Manufactured in Class‑10,000 sterile clean workshops, the product can effectively block moisture and microbial invasion for a long time and reduce losses during storage and transportation. It is flexibly compatible with various administration devices such as pen‑type injectors and automatic infusion pumps, greatly improving filling efficiency, safety in storage & transportation and clinical ease‑of‑use.
Following the upgrading trend of the pharmaceutical packaging industry, Triumph Junheng has made forward‑looking arrangements for the cartridge business. The products comply not only with the domestic Chinese standard YBB00132004‑2015, but also with ISO requirements and major pharmacopoeias of the United States, Europe and Japan. This strongly supports drug registration and commercialization both at home and overseas, and consolidates the foundation for large‑scale application of high‑end drug‑delivery packaging.
Superior product performance is the core guarantee for regulatory compliance. Relying on self‑produced high‑quality medium‑borosilicate glass tubes, Triumph Junheng cartridges establish quality advantages from the source. They can withstand a wide temperature range from 40 ℃ to 130 ℃ and resist breakage during high‑temperature sterilization; heavy‑metal leaching is far below the specified limits. The product portfolio covers regular capacities from 1 ml to 10 ml. Four delivery forms are available: bare cartridges, finished products with rubber stoppers, finished products with aluminum‑plastic caps, and tray‑packed finished assemblies. Finished goods are sterilized before delivery and meet Grade‑A cleanliness requirements for filling. They are suitable for storage and clinical administration of high‑end biological preparations including monoclonal antibodies, peptides, new‑generation vaccines and long‑acting injectables.
Personalized customization is also available. Inner diameter, cartridge length, inner‑wall silicon‑coating process and other parameters can be adjusted according to customers’ filling production lines and drug‑registration requirements worldwide to satisfy regional regulatory compliance globally.
Going forward, the company will continue to expand its footprint in high‑end drug‑delivery systems, strive to build a complete full‑product chain for pharmaceutical packaging materials, establish an integrated R&D, manufacturing and service platform, and consistently supply large‑volume, high‑quality and long‑term stable products for pharmaceutical customers across the globe.